Status:
COMPLETED
Comparative Outcomes of Endoscopic and Open Carpal Tunnel Release with Neurotrophic Supplementation in Severe Carpal Tunnel Syndrome
Lead Sponsor:
University of Bari
Conditions:
Carpal Tunnel Syndrome (CTS)
Eligibility:
All Genders
18+ years
Brief Summary
This study addresses the pressing clinical question of optimizing surgical and pharmacological interventions for severe Carpal Tunnel Syndrome (CTS), a prevalent and debilitating condition caused by m...
Eligibility Criteria
Inclusion
- clinically and electromyographically confirmed severe CTS (SCV \< 35 m/s)
- experienced persistent symptoms unresponsive to conservative treatments for at least six months
Exclusion
- mild or moderate CTS
- concomitant neuropathies
- previous carpal tunnel surgeries
- contraindications to neurotrophic supplementation
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
497 Patients enrolled
Trial Details
Trial ID
NCT06902831
Start Date
June 1 2022
End Date
April 1 2024
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico di Bari
Bari, Italy, Italy